Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > Research > Genetic heart disease

Genetic heart disease

Around 40 cardiovascular conditions are caused by underlying genetic faults that can directly result in sudden cardiac death.

Over 25,000 Australians die every year from sudden cardiac death (SCD). The most frequent cause of SCD is an underlying inherited heart disease for those aged 35 years and under.

Inherited or genetic heart diseases are a collection of heart muscle diseases and electrical rhythm disorders. Hypertrophic cardiomyopathy (HCM) is the most common disease, affecting up to 1 in 500 people.

While major advances have been made in our understanding of the clinical and genetic basis of inherited heart diseases. Genetic testing fails to identify a cause of disease for many families and there are currently limited therapeutic options available.

At Centenary our research is focused on understanding the clinical and genetic basis of inherited heart disease. We use a range of approaches including human gene discovery studies, basic cellular systems and population-based psychosocial and public health studies.

Our major goal is to reduce human disease by combining basic science research and clinical cardiology.
We have developed cohorts and national registries of patients and families with inherited heart diseases. We then utilise the latest in genetic technology in order to form the basis of our novel gene discovery studies.

Our research encompasses basic DNA and stem cell science, clinical research in patients, and public health initiatives. Most importantly, we have the key clinical resources, including studies of individual patients and families, which form the basis of all our genetic studies.

Professor Chris Semsarian AM, Head of Agnes Ginges Centre of Molecular Cardiology leads this research.

Our ability to read DNA sequence has far exceeded our ability to recognise which genetic variants cause inherited diseases. To address this shortcoming, we develop new computer-based approaches and laboratory-based assays to find disease-causing genetic variants.

Our research focus is to increase the diagnostic yield of genetic testing and to develop new therapeutics for inherited heart diseases. This is achieved by developing improved diagnostic genetic tests and by exploring the therapeutic potential of small molecules in cultures of heart cells that we grow from our patient’s blood.

Our work translates to more families receiving a genetic diagnosis, which improves clinical management. Working to develop novel therapeutic molecules using stem cell technology brings together highly innovative technologies at the cutting edge of human genetics research.

Dr Richard Bagnall, Head of Bioinformatics and Human Genetics Laboratory leads this research.

Icons with Text on Sidebar

  • Sudden cardiac death (SCD) occurs in 25,000 people each year in Australia

  • At least 40 heart conditions that are directly caused by a fault in our genetic make-up

  • Up to 1 in 500 people have Hypertrophic cardiomyopathy (HCM)

Themes

  • Cardiovascular

    Cardiovascular

Research Field Type

  • Diseases

All Research fields

  • Alzheimer's disease

  • AML – Acute Myeloid Leukaemia

  • Asthma

  • Bioinformatics

  • COPD – Chronic obstructive pulmonary disease

  • COVID-19

  • Diabetes

  • Epigenetics

  • GvHD – Graft vs Host Disease

  • Liver disease

  • Lung Cancer

  • Melanoma

  • Tuberculosis

Our major goal is to reduce human disease by combining basic science research and clinical cardiology.
We have developed cohorts and national registries of patients and families with inherited heart diseases. We then utilise the latest in genetic technology in order to form the basis of our novel gene discovery studies.

Our research encompasses basic DNA and stem cell science, clinical research in patients, and public health initiatives. Most importantly, we have the key clinical resources, including studies of individual patients and families, which form the basis of all our genetic studies.

Professor Chris Semsarian AM, Head of Agnes Ginges Centre of Molecular Cardiology leads this research.

Our ability to read DNA sequence has far exceeded our ability to recognise which genetic variants cause inherited diseases. To address this shortcoming, we develop new computer-based approaches and laboratory-based assays to find disease-causing genetic variants.

Our research focus is to increase the diagnostic yield of genetic testing and to develop new therapeutics for inherited heart diseases. This is achieved by developing improved diagnostic genetic tests and by exploring the therapeutic potential of small molecules in cultures of heart cells that we grow from our patient’s blood.

Our work translates to more families receiving a genetic diagnosis, which improves clinical management. Working to develop novel therapeutic molecules using stem cell technology brings together highly innovative technologies at the cutting edge of human genetics research.

Dr Richard Bagnall, Head of Bioinformatics and Human Genetics Laboratory leads this research.

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram